MAYNE PHARMA FDA Approval ANDA 073607

ANDA 073607

MAYNE PHARMA

FDA Drug Application

Application #073607

Application Sponsors

ANDA 073607MAYNE PHARMA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL25MG;250MG0CARBIDOPA AND LEVODOPACARBIDOPA; LEVODOPA

FDA Submissions

ORIG1AP1992-08-28
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-12-27
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1997-10-28
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1999-02-12
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1999-02-12
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1999-12-02
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1999-12-02
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2002-01-04
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2002-01-04
LABELING; LabelingSUPPL15AP2001-11-06
LABELING; LabelingSUPPL18AP2007-03-26
LABELING; LabelingSUPPL23AP2009-10-30
MANUF (CMC); Manufacturing (CMC)SUPPL26AP2011-02-03
LABELING; LabelingSUPPL27AP2011-07-05
LABELING; LabelingSUPPL28AP2015-11-05STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL10Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL23Null7
SUPPL27Null7
SUPPL28Null7

TE Codes

001PrescriptionAB

CDER Filings

MAYNE PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 73607
            [companyName] => MAYNE PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CARBIDOPA AND LEVODOPA","activeIngredients":"CARBIDOPA; LEVODOPA","strength":"25MG;250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CARBIDOPA AND LEVODOPA","submission":"CARBIDOPA; LEVODOPA","actionType":"25MG;250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.